This summer, our team headed to Washington, D.C. for the 33rd Congress of the International Society on Thrombosis and Haemostasis (ISTH). It was an event we won’t forget.
We were proud to officially launch IMPACT, our brand-new platelet function analyser designed to support fast, reliable results in both laboratory and point-of-care settings. From live demos to great conversations, it was exciting to see so many people stop by Booth 139 to learn more and get hands-on with the analyser.
With such an important milestone for Hart, we brought a great team over to the USA including Alex, Keighley, Heike, Jack, Thomas, Daniel and Jon. It was a brilliant mix of technical, strategic and leadership perspectives, and a proud moment to represent the company on a global stage.
The response to IMPACT has been brilliant. We had meaningful conversations with clinicians, researchers and partners from around the world, and the interest in what IMPACT can bring to platelet function testing was clear.
To round off a successful week, our team attended a post-congress gathering hoste
d by DiaPharma, our U.S. distributor for the IMPACT analyser. It was a brilliant way to celebrate the start of what promises to be a strong and exciting partnership.
Want to learn more?
Visit impactplatelet.com for updates, insights and the latest news on the rollout.
IMPACT is due for release in 2026 and will shortly be available for Research Use Only (RUO).
Thank you to everyone who came by to see us at ISTH 2025. Your support, questions and feedback mean a lot, and we’re more excited than ever for what’s ahead.
